A retrospective study analysing effects of tofogliflozin on adrenocorticotropic hormone, renin and aldosterone, and cortisol levels in elderly patients with diabetes mellitus
Latest Information Update: 04 Jan 2022
At a glance
- Drugs Tofogliflozin (Primary) ; Angiotensin receptor antagonists; Biguanides; Calcium channel antagonists; Dipeptidyl peptidase 4 inhibitors; Diuretics; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
Most Recent Events
- 04 Jan 2022 New trial record
- 12 Nov 2021 Results published in the Medicine